News Focus
News Focus
Followers 27
Posts 12075
Boards Moderated 0
Alias Born 01/02/2003

Re: None

Wednesday, 04/07/2021 8:49:38 AM

Wednesday, April 07, 2021 8:49:38 AM

Post# of 140538
Titan Medical initiated buy at Oppenheimer

Titan Medical (NASDAQ:TMDI) has surged ~25.7% after Oppenheimer initiated its coverage with an outperform rating and the price target of $4.00 per share implies ~123.5% upside to the previous close.
The analyst calls Titan Medical an ‘attractive micro-cap play’ with the company’s collaboration with Medtronic underlying the thesis.

"The Investors's Chief Problem--and even his worst enemy--is likely to be himself"
---Benjamin Graham

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now